Aiding the advancement of Alzheimer’s treatment
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Zombie Data: The silent threat to real-world data in life sciences
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "...
Maternal mental health matters
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
How to Target the Right Physicians Using Trigger Programs
As therapies become increasingly complex and personalized, it is imperative that physicians...
The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Demonstrating the Value of Digital Health Post Pandemic
As life settles into the new normal after the worst of the COVID-19 pandemic, it is clear that...
The Fight Continues: Battling the COVID Evolution
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
A Ready-Made Solution for Accelerating RSV Research
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
Lessons Learned from COVID-19 Clinical Trials
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Four Steps to Linking Clinical Trial and Real-World Data
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...